Tokyo - Delayed Quote JPY

Fuji Oil Company, Ltd. (5017.T)

297.00

-1.00

(-0.34%)

At close: 3:30:00 PM GMT+9

Marvell Technology, Netflix, Zscaler: Trending Tickers

Marvell Technology (MRVL) stock is dropping Friday morning despite reporting major revenue growth in its AI data center business and its guidance figure coming in line with Wall Street expectations. Netflix (NFLX) receives year-end price target hikes from analyst teams at Bank of America and Evercore ISI. Zscaler (ZS) shares is moving higher after topping guidance expectations and lifting its full-year earnings outlook. Catalysts host Madison Mills and her guest host, Prairie Operating Co. EVP of Market Strategy Lou Basenese, tackle several of these trending stock tickers. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Yahoo Finance Video 31 minutes ago

NFLX

MRVL

ZS
How this Nvidia rival is trying to take chunks of its market share

Groq founder and CEO Jonathan Ross says the company has an advantage in nimbleness and speed.

Yahoo Finance 2 hours ago

GROQ.PVT

NVDA

CSCO
Ulta Beauty earnings, Zscaler outlook: After-Hours Movers

Ulta Beauty (ULTA) shares are soaring in extended hours after the cosmetic company beat first quarter earnings estimates. Zscaler (ZS) stock is also gettng a lift into positiver territory after it lifted its full-year earnings outlook. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here.

Yahoo Finance Video 18 hours ago

ULTA

ZS
Marvell's narrow Q1 earnings beat fails to wow Wall Street

Marvell Technology (MRVL) stock is under pressure after the company's first quarter results came in just above expectations. First quarter net revenue was $1.9 billion in the first quarter, beating estimates of $1.88 billion, while adjusted earnings per share (EPS) were $0.62, above the expected $0.61. The company's sales and earnings outlook for the upcoming quarter were roughly in line with analyst estimates. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 18 hours ago

MRVL
Dell blows past Q2 guidance expectations. Stock gets lift.

Dell Technologies (DELL) posted mixed first quarter results on Thursday, releasing net revenue figures of $23.38 billion (vs. estimates of $23.15 billion) while adjusted earnings came out to $1.55 per share (shy of estimates for $1.69). Julie Hyman and Josh Lipton dive into Dell's report as the computer company's second quarter revenue forecasts blew past Wall Street consensus and where it stands amid AI server demands. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 19 hours ago

DELL
Marvell Shares Tumble Amid Concerns Over Next-Gen AI Ramp

Marvell Shares Slide Amid Mixed Analyst Notes

GuruFocus.com 28 minutes ago

MRVL
UiPath Tops Q1, Raises FY26 Guidance

UiPath sees $1.55 billion revenue versus $1.52 billion consensus as ARR hits $1.69 billion

GuruFocus.com 31 minutes ago

PATH
COPD Drug Developed by Regeneron, Sanofi Fails Key Test

A COPD treatment for former smokers developed by Regeneron Pharmaceuticals and Sanofi failed to meet its primary endpoint in one Phase 3 trial.

Investopedia 45 minutes ago

REGN

SNY
Nvidia and Dell Team Up to Build Department of Energy Supercomputer

Dell's Liquid-Cooled Leap: Nvidia Partnership Fuels DOE's AI Push

GuruFocus.com 47 minutes ago

NVDA

DELL
Red Robin Stock Soars 75% After Restaurant Chain Posts Unexpected Profit

Shares of Red Robin Gourmet Burgers surged 75% in early trading Friday, a day after the casual restaurant chain swung to a surprising first-quarter profit.

Investopedia 56 minutes ago

RRGB
Ulta Stock Jumps as Beauty Product Spending Continues

Ulta Beauty exceeded profit and sales estimates as consumers look to beauty products as a "comfort and escape."

Investopedia 1 hour ago

ULTA
UiPath Stock Rises After Earnings, Guidance Hike. Why Wall Street Is More Cautious.

The automation-software company pushed back on fears that cuts in U.S. federal spending may hurt its financial results.

Barrons.com 1 hour ago

PATH
Zscaler Stock Jumps. Why It’s Defying the Cybersecurity Earnings Slump.

The cybersecurity stock rose early Friday, making it an outlier in what's been a tough earnings season for the sector.

Barrons.com 1 hour ago

ZS
Costco Defies Tariff Shifts With Higher Profit, Lower Prices

(Bloomberg) -- Costco Wholesale Corp. posted better-than-expected earnings in the third quarter, a sign that the nation’s largest club chain is flexing its scale and devoted following to navigate tariffs and economic turbulence. Most Read from BloombergNYC Congestion Toll Brings In $216 Million in First Four MonthsNow With Colorful Blocks, Tirana’s Pyramid Represents a Changing AlbaniaThe Economic Benefits of Paying Workers to MoveNY Wins Order Against US Funding Freeze in Congestion FightBillio

Bloomberg 1 hour ago

KHC

TGT

WMT
Airbnb, Zscaler downgraded: Wall Street's top analyst calls

Airbnb, Zscaler downgraded: Wall Street's top analyst calls

The Fly 1 hour ago

ABNB

ZS

PVH
Gap Stock Slides; Company Warns of Up to $300 Million in Tariff Costs

Gap estimates tariffs will add up to $300 million in costs this year, but says it doesn't plan to raise prices to offset levies. The company behind Old Navy, Banana Republic and its namesake brand said its total tariff-related costs will be between $250 million and $300 million if current rates remain. Chief Executive Richard Dickson said the company plans to double its sourcing of American cotton.

The Wall Street Journal 1 hour ago

GAP
Stocks to Watch Friday: Costco, Ulta, Dell, Regeneron

↗️ Costco (COST): The warehouse-club chain logged higher profit and outlined tariff-mitigating measures it says have helped avoid price hikes. It said prices were down for items including eggs, butter and olive oil.

The Wall Street Journal 1 hour ago

ULTA
Summit Therapeutics Study Is a Win for China Biopharma Deals. Why the Stock Is Down.

The trial was meant to answer the biggest question in biotech: What happens when U.S. companies test promising new Chinese cancer immunotherapies in western countries?

Barrons.com 1 hour ago

SMMT
Summit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile Failure

Summit Therapeutics stock plunged Friday after its highly watched cancer drug failed to significantly improve overall survival.

Investor's Business Daily 1 hour ago

SMMT

MRK
Zscaler Had 'Breakout' Third Quarter Amid Strong Demand for AI Security Solutions, Wedbush Says

Zscaler's (ZS) fiscal third-quarter results marked another "breakout" moment for the company as it c

PREMIUM
MT Newswires 1 hour ago

ZS

Performance Overview

Return	5017.T	Nikkei 225 (^N225)
YTD	+1.67%	-4.84%
1-Year	-38.01%	-0.23%
3-Year	+3.62%	+38.71%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Fuji Oil Company, Ltd. (5017.T)

Related News

Marvell Technology, Netflix, Zscaler: Trending Tickers

How this Nvidia rival is trying to take chunks of its market share

Ulta Beauty earnings, Zscaler outlook: After-Hours Movers

Marvell's narrow Q1 earnings beat fails to wow Wall Street

Dell blows past Q2 guidance expectations. Stock gets lift.

Marvell Shares Tumble Amid Concerns Over Next-Gen AI Ramp

UiPath Tops Q1, Raises FY26 Guidance

COPD Drug Developed by Regeneron, Sanofi Fails Key Test

Nvidia and Dell Team Up to Build Department of Energy Supercomputer

Red Robin Stock Soars 75% After Restaurant Chain Posts Unexpected Profit

Ulta Stock Jumps as Beauty Product Spending Continues

UiPath Stock Rises After Earnings, Guidance Hike. Why Wall Street Is More Cautious.

Zscaler Stock Jumps. Why It’s Defying the Cybersecurity Earnings Slump.

Costco Defies Tariff Shifts With Higher Profit, Lower Prices

Airbnb, Zscaler downgraded: Wall Street's top analyst calls

Gap Stock Slides; Company Warns of Up to $300 Million in Tariff Costs

Stocks to Watch Friday: Costco, Ulta, Dell, Regeneron

Summit Therapeutics Study Is a Win for China Biopharma Deals. Why the Stock Is Down.

Summit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile Failure

Zscaler Had 'Breakout' Third Quarter Amid Strong Demand for AI Security Solutions, Wedbush Says

Performance Overview